Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Punit P Seth

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Organic Chemistry|August 14, 2013
A constrained tricyclic nucleic acid analogue of α-L-LNA: investigating the effects of dual conformational restriction on duplex thermal stabilityStephen Hanessian, Jernej Wagger, Bradley L Merner, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2012
Structure-based design of a highly constrained nucleic acid analogue: improved duplex stabilization by restricting sugar pucker and torsion angle γStephen Hanessian, Benjamin R Schroeder, Robert D Giacometti, et al.
Chemical Communications (Cambridge, England)|May 23, 2012
Structure and nuclease resistance of 2',4'-constrained 2'-O-methoxyethyl (cMOE) and 2'-O-ethyl (cEt) modified DNAsPradeep S Pallan, Charles R Allerson, Andres Berdeja, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Fluorinated Nucleotide Modifications Modulate Allele Selectivity of SNP-Targeting Antisense OligonucleotidesMichael E Østergaard, Josh Nichols, Timothy A Dwight, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2018
Evaluation of the effect of 2'-O-methyl, fluoro hexitol, bicyclo and Morpholino nucleic acid modifications on potency of GalNAc conjugated antisense oligonucleotides in miceThazha P Prakash, Jinghua Yu, Garth A Kinberger, et al.
Nucleic Acid Therapeutics|February 10, 2018
Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the LiverColton M Miller, Michael Tanowitz, Aaron J Donner, et al.
Nucleic Acid Therapeutics|May 25, 2022
Targeted Delivery of Antisense Oligonucleotides Through Angiotensin Type 1 ReceptorCarol Kuo, Mehran Nikan, Steve T Yeh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2010
Inhibitor-induced structural change in the HCV IRES domain IIa RNARyan B Paulsen, Punit P Seth, Eric E Swayze, et al.
Journal of Medicinal Chemistry|December 18, 2008
Short antisense oligonucleotides with novel 2'-4' conformationaly restricted nucleoside analogues show improved potency without increased toxicity in animalsPunit P Seth, Andrew Siwkowski, Charles R Allerson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2017
Antisense Reduction of Mutant COMP Reduces Growth Plate Chondrocyte PathologyKaren L Posey, Francoise Coustry, Alka C Veerisetty, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Organic Chemistry|August 14, 2013
A constrained tricyclic nucleic acid analogue of α-L-LNA: investigating the effects of dual conformational restriction on duplex thermal stabilityStephen Hanessian, Jernej Wagger, Bradley L Merner, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2012
Structure-based design of a highly constrained nucleic acid analogue: improved duplex stabilization by restricting sugar pucker and torsion angle γStephen Hanessian, Benjamin R Schroeder, Robert D Giacometti, et al.
Chemical Communications (Cambridge, England)|May 23, 2012
Structure and nuclease resistance of 2',4'-constrained 2'-O-methoxyethyl (cMOE) and 2'-O-ethyl (cEt) modified DNAsPradeep S Pallan, Charles R Allerson, Andres Berdeja, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Fluorinated Nucleotide Modifications Modulate Allele Selectivity of SNP-Targeting Antisense OligonucleotidesMichael E Østergaard, Josh Nichols, Timothy A Dwight, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2018
Evaluation of the effect of 2'-O-methyl, fluoro hexitol, bicyclo and Morpholino nucleic acid modifications on potency of GalNAc conjugated antisense oligonucleotides in miceThazha P Prakash, Jinghua Yu, Garth A Kinberger, et al.
Nucleic Acid Therapeutics|February 10, 2018
Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the LiverColton M Miller, Michael Tanowitz, Aaron J Donner, et al.
Nucleic Acid Therapeutics|May 25, 2022
Targeted Delivery of Antisense Oligonucleotides Through Angiotensin Type 1 ReceptorCarol Kuo, Mehran Nikan, Steve T Yeh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2010
Inhibitor-induced structural change in the HCV IRES domain IIa RNARyan B Paulsen, Punit P Seth, Eric E Swayze, et al.
Journal of Medicinal Chemistry|December 18, 2008
Short antisense oligonucleotides with novel 2'-4' conformationaly restricted nucleoside analogues show improved potency without increased toxicity in animalsPunit P Seth, Andrew Siwkowski, Charles R Allerson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2017
Antisense Reduction of Mutant COMP Reduces Growth Plate Chondrocyte PathologyKaren L Posey, Francoise Coustry, Alka C Veerisetty, et al.
Pageof 11